Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I/II Study Of Bevacizumab (rhuMAb VEGF) In Combination With OSI-774 For Patients With Recurrent Or Metastatic Cancer Of The Head And Neck

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00055913
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:08.357572+00:00
Published At
2018-10-02T00:00:00+00:00
Record Updated At
2018-10-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Squamous Cell Carcinoma of the Hypopharynx", "Recurrent Squamous Cell Carcinoma of the Larynx", "Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity", "Recurrent Squamous Cell Carcinoma of the Nasopharynx", "Recurrent Squamous Cell Carcinoma of the Oropharynx", "Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity", "Salivary Gland Squamous Cell Carcinoma", "Stage IV Squamous Cell Carcinoma of the Hypopharynx", "Stage IV Squamous Cell Carcinoma of the Larynx", "Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity", "Stage IV Squamous Cell Carcinoma of the Nasopharynx", "Stage IV Squamous Cell Carcinoma of the Oropharynx", "Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-10-02"
protocolSection.identificationModule.nctId
"NCT00055913"
protocolSection.identificationModule.officialTitle
"A Phase I/II Study Of Bevacizumab (rhuMAb VEGF) In Combination With OSI-774 For Patients With Recurrent Or Metastatic Cancer Of The Head And Neck"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Recurrent Squamous Cell Carcinoma of the Hypopharynx (protocolSection.conditionsModule.conditions)
  • Recurrent Squamous Cell Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity (protocolSection.conditionsModule.conditions)
  • Recurrent Squamous Cell Carcinoma of the Nasopharynx (protocolSection.conditionsModule.conditions)
  • Recurrent Squamous Cell Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)
  • Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
  • Salivary Gland Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Hypopharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Nasopharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.